CONTACT US  |  CAREERS  |  LOCATE US  |  DOWNLOADS  |  BLOG
CONNECT WITH US ON
Financial Services | Broking & Distribution | Institutional Equities | Private Wealth Management | Investment Banking | Private Equity | Asset Management | Commodities | Home Finance
Broking & Distribution > Markets > Company Information > News

Aurobindo Pharma Ltd

BSE Code : 524804   |   NSE Symbol : AUROPHARMA   |   ISIN : INE406A01037
OVERVIEW INFORMATION FINANCIALS COMPANY NEWS CORPORATE ACTIONS
 
Aurobindo Pharma acquires select Western Europe businesses  01-Apr-2014 | 17:51
Aurobindo Pharma has completed the acquisition of certain commercial operations in Western Europe from Actavis plc (NYSE: ACT). The agreement to acquire Actavis operations was announced in January 2014. Powered by Capital Market - Live News...
  Company Information :   Company List A-Z  |   Snapshot  |   Technical Charts  |   Investor Returns  |   Score Board  |   Company Peer Comparison  |   Background  |   Board of Directors  |   Quarterly Results  |   Balance Sheet  |   Share Holding Pattern  |   MF Holdings  |   Profit & Loss  |   Key Ratios / Cash Flow  |   Company News  |   Bonus / Split / Rights  |   Dividend / Book Closure  |   Capital Structure  |   Insider Trading History  |   Top Companies By MCAP  |   Top Dividend Yield  
  Equity Market       Derivatives       Mutual Funds       Commodities       Currencies       News       IPO    
Login
Login Open An Account Trade Now
50% Cash Back
Open an account
Name :
Mobile :
Email :
State :
City :
Interested in :
*Terms & Conditions
Financial Services Products & ServicesBusiness PartnerMarket InfoResearchQuick LinksBusinesses
Stocks   A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Mutual Funds   A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Disclaimer | Additional Disclaimer for U.S. Persons  | Feedback | Locate Us | Do Not Call Form
Motilal Oswal Securities Ltd. (MOSL) Member of NSE, BSE and MCX-SX
Reg. Office: Palm Spring Centre, 2nd Floor, Palm Court Complex, New Link Road, Malad (West), Mumbai 400 064. Tel: 022 3080 1000

Customer having any query / feedback / clarification may write to query@motilaloswal.com
In case of grievances for Securities Broking write to grievances@motilaloswal.com, for DP to dpgrievances@motilaloswal.com, for Commodity Broking to commoditygrievances@motilaloswal.com and for NBFC to lasgrievances@motilaloswal.com

Registration Nos.: NSE (Cash): INB231041238; NSE (F&O): INF231041238 ; NSE (CD) INE231041238 , BSE (Cash): INB011041257; BSE(F&O): INF011041257; BSE(CD); MCX-SX (Cash) INB261041231; MCX-SX (F&O) INF261041231; MCX-SX (CD) INE261041231; CDSL: IN-DP-CDSL-09-99 ; NSDL : IN-DP-NSDL-152-2000; AMFI :ARN 17397 *PMS (Regn No. : INP000000670) & Mutual funds are offered through Motilal Oswal Asset Management Company (MOAMC) which is group company of MOSL. PMS (Regn No. INP000004409) is offered through Motilal Oswal Wealth Management Ltd. (MOWML) which is group company of Motilal Oswal Securities Ltd *Motilal Oswal Commodities Broker Pvt Ltd (MOCBPL) member of MCX, NCDEX, NCDEX SPOT. MCX Member ID 29500, NCDEX – NCDEX-CO-04-00114, NCDEX Spot Exchange Limited 10014. FMC Unique membership code: MCX: MCX/TCM/CORP/0725, NCDEX: NCDEX/TCM/CORP/0033, Commodity Services are offered through MOCBPL which is a group company of MOSL. Motilal Oswal Securities Ltd is a Distributor of Mutual Fund, and IPOs . *Investment in securities is subject to market risk

Motilal Oswal Securities International Pvt Limited CRD-164319 SEC - 08-69093
Copyright © 2013 MOSL. All Rights Reserved. Market Data provided by C-MOTS Infotech (ISO 9001:2008 Certified)

Site best viewed in IE 7.0+, Mozila Firefox 3.0+ and Google Chrome at 1024 x 768 pixels resolution

GET QUOTES    RESEARCH REPORT  
Our research reports can be searched based on companies covered (COM), sectors covered (SEC) or report names (RPT). Type any three characters of your query to see a search list.